1. Home
  2. GGB vs CYTK Comparison

GGB vs CYTK Comparison

Compare GGB & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gerdau S.A.

GGB

Gerdau S.A.

HOLD

Current Price

$3.72

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$60.70

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGB
CYTK
Founded
1901
1997
Country
Brazil
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.6B
IPO Year
2000
2004

Fundamental Metrics

Financial Performance
Metric
GGB
CYTK
Price
$3.72
$60.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
18
Target Price
$4.60
$86.00
AVG Volume (30 Days)
24.0M
1.6M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
2.56%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,368,000.00
Revenue This Year
$4.94
$37.53
Revenue Next Year
$4.36
$214.81
P/E Ratio
$13.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.27
$29.31
52 Week High
$4.66
$70.98

Technical Indicators

Market Signals
Indicator
GGB
CYTK
Relative Strength Index (RSI) 31.02 38.75
Support Level $2.84 $59.23
Resistance Level $3.73 $65.93
Average True Range (ATR) 0.11 2.59
MACD -0.05 -0.74
Stochastic Oscillator 8.92 9.49

Price Performance

Historical Comparison
GGB
CYTK

About GGB Gerdau S.A.

Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutors, mechanical construction bars, and reinforced steel locks. The company's geographical segment includes Brazil Operations; North America Operations; South America Operations as well as Special Steel Operations. It derives the majority of its revenue from the Brazil Operations segment.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: